Literature DB >> 6215416

Reversible inhibition by human serum lipoproteins of cell proliferation.

F Ito, Y Takii, J Suzuki, Y Masamune.   

Abstract

Normal human serum or plasma was studied for the presence of inhibitors of cell proliferation by assaying inhibition of incorporation of labeled thymidine into acid-insoluble fraction using human FL cells. Lipoprotein fraction obtained by gel filtration through Sepharose 4B and by KBr density gradient centrifugation was found to play a major part of the inhibitory activity of the serum. It was also shown that the inhibitory activity resides in low-density lipoprotein (LDL). The addition of the lipoprotein fraction to growing FL cells caused an early decrease in the transport of uridine and thymidine across the membrane. This change in the permeability of membrane was followed by the preferential inhibition of DNA synthesis and a reduction in the percentage of mitotic cells in the cell population. The inhibition of the growth was reversible and was observed in various types of cells irrespective of species.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215416     DOI: 10.1002/jcp.1041130102

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

1.  Characterization of human plasma growth inhibitory activity on serum-free mouse embryo cells.

Authors:  P D Weisz; D W Barnes
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-06       Impact factor: 2.416

2.  Characterization of a growth-inhibiting protein present in rat serum that exerts a differential effect on in vitro growth of nonmalignant rat liver cells when compared with Rous sarcoma virus-transformed rat liver cells.

Authors:  K Miyazaki; K Mashima; N Yamashita; J Yamashita; T Horio
Journal:  In Vitro Cell Dev Biol       Date:  1985-01

3.  Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60.

Authors:  M K Cathcart; G M Chisolm; A K McNally; D W Morel
Journal:  In Vitro Cell Dev Biol       Date:  1988-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.